Tumor cell lysates as immunogenic sources for cancer vaccine design
about
Role of Dendritic Cells in the Induction of Lymphocyte ToleranceSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyAdjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies.Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice.A retrospective analysis comparing APCEDEN(®) dendritic cell immunotherapy with best supportive care in refractory cancer.Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies.Dendritic Cell Therapies for Hematologic Malignancies.Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy.Investigation of tumor-tumor interactions in a double human cervical carcinoma xenograft model in nude mice.Cancer stem cells as targets for DC-based immunotherapy of colorectal cancerPEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy
P2860
Q26779405-AAA1E6C8-7E38-46EB-A33F-C82C6797AFB2Q28080262-FFD37B41-1DA1-4653-B0B9-3C865396161EQ37357786-136F505D-CE74-4A6E-8D49-66AA82EB3AD6Q37662531-437C4E6F-A051-4E74-81D2-9D26FE1A4385Q37687530-47D2A37C-9647-45C6-A39F-52BCD7FAA930Q38609735-9E30B742-75E1-438D-BCBA-B349BE10A483Q38847756-15B1A0E9-2E51-4901-BB80-C5601B1F5553Q39289930-E2DFF016-A930-4341-B9F7-77F7C15F58E1Q41619582-B4F846EA-D21C-4CF8-B38E-E2841E189539Q51068276-512E6A4E-C7C4-4A66-BF83-D07A3C5899A5Q52571242-103A9038-3CEE-4930-AE44-755ACD2B4EB0Q52746279-B188B96E-71C3-4D76-92AF-C3B21C5F92E4Q55221792-D7054CE3-DB76-4EB9-90EE-141891F4757BQ55424327-277EAACD-5FC9-465D-A7A4-C2B34841542AQ58786746-BB5F8EF6-7E56-4397-BEC1-994E4918BBF5Q58792025-76C11D96-D418-49A4-BE43-4FEA900A8D22
P2860
Tumor cell lysates as immunogenic sources for cancer vaccine design
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor cell lysates as immunogenic sources for cancer vaccine design
@ast
Tumor cell lysates as immunogenic sources for cancer vaccine design
@en
Tumor cell lysates as immunogenic sources for cancer vaccine design
@nl
type
label
Tumor cell lysates as immunogenic sources for cancer vaccine design
@ast
Tumor cell lysates as immunogenic sources for cancer vaccine design
@en
Tumor cell lysates as immunogenic sources for cancer vaccine design
@nl
prefLabel
Tumor cell lysates as immunogenic sources for cancer vaccine design
@ast
Tumor cell lysates as immunogenic sources for cancer vaccine design
@en
Tumor cell lysates as immunogenic sources for cancer vaccine design
@nl
P2093
P2860
P3181
P1476
Tumor cell lysates as immunogenic sources for cancer vaccine design
@en
P2093
Alejandra Gleisner
Felipe Falcón-Beas
Fermín E González
Flavio Salazar-Onfray
Mercedes N López
P2860
P304
P3181
P356
10.4161/21645515.2014.982996
P407
P577
2014-01-01T00:00:00Z